Publications
Güven DC, Thong MS, Arndt V. (2024) Survivorship outcomes in patients treated with immune checkpoint inhibitors: a scoping review. J Cancer Surviv https://doi.org/10.1007/s11764-023-01507-w
Giusti F, Martos C, Trama A, Bettio M, Sanvisens A, Audisio R, Arndt V, . . . ENCR Working Group on Treatment Data Harmonisation (2023). Cancer treatment data available in European cancer registries: Where are we and where are we going? Front Oncol, 13, 1109978. https://doi.org/10.3389/fonc.2023.1109978
Arndt V, Hernandez D, Schlander M. (2022). Einkommenseinbußen nach Krebs – Ergebnisse aus Deutschland. Die Onkologie 28 (11), 951-956. https://doi.org/10.1007/s00761-022-01243-3
Cabasag CJ, Vignat J, Ferlay J, Arndt V, Lemmens V, Praagman J, Bray F, Soerjomataram I. (2022). The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020. Eur J Cancer, 177, 15-24. https://doi.org/10.1016/j.ejca.2022.09.030
Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, . . . Arndt V. (2022). Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors. J Cancer Res Clin Oncol. 148(12) 3461-3473 https://doi.org/10.1007/s00432-022-04204-w
Eckford RD, Gaisser A, Arndt V, Baumann M, Kludt E, Mehlis K, . . . Schlander M. (2022). The COVID-19 Pandemic and Cancer Patients in Germany: Impact on Treatment, Follow-Up Care and Psychological Burden. Front Public Health, 9, 788598. https://doi.org/10.3389/fpubh.2021.788598
Eyl-Armbruster RE, Thong MSY, Carr PR, Jansen L, Chang-Claude J, Hoffmeister M, Brenner H, Arndt V. Change Toward Healthier Lifestyles Is Associated With Better Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors. J Natl Compr Canc Netw, 20(11), 1233-1243. https://doi.org/10.6004/jnccn.2022.7049
Feller A, Arndt V (2022). Epidemiologie bösartiger Knochentumoren in Deutschland 2004–2018. Die Onkologie, 28(7), 551-554. https://doi.org/10.1007/s00761-022-01190-z
Gaisser A, Eckford RD, Arndt V, Doege D, Kludt E, Ubels J, . . . Weg-Remers S. (2022). Nearly two years of the coronavirus pandemic from the perspective of people affected by cancer. Onkologe (Berl), 28(3), 248-252. https://doi.org/10.1007/s00761-022-01096-w
Scherer-Trame S, Jansen L, Koch-Gallenkamp L, Arndt V, Chang-Claude J, Hoffmeister M, Brenner .H (2022). Quality of life, distress, and posttraumatic growth 5 years after colorectal cancer diagnosis according to history of inpatient rehabilitation. J Cancer Res Clin Oncol, 148(11), 3015-3028. https://doi.org/10.1007/s00432-021-03865-3
Schneider J, Hernandez D, CAESAR study group, Schlander M, Arndt V. (2022). Out-of-pocket payments and loss of income among long-term breast cancer survivors in Germany: a multi-regional population-based study. J Cancer Surviv 2022 Dec 2. https://doi.org/10.1007/s11764-022-01293-x
Thong MSY, Doege D, Weisser L, Koch-Gallenkamp L, Bertram H, Eberle A., . . . Arndt V. (2022). Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study. J Cancer Res Clin Oncol, 148(1), 155-162. https://doi.org/10.1007/s00432-021-03825-x
van Leeuwen M, Kieffer JM, Young TE, Annunziata M A, Arndt V, Arraras JI, . . . Eortc QLG. (2022). Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire. J Cancer Surviv. https://doi.org/10.1007/s11764-021-01160-1
Yang K, Liu Z, Thong MSY, Doege D, Arndt V. (2022). Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis. Cancers (Basel), 14(7), 1808. https://doi.org/10.3390/cancers14071808
2021
Arndt V. (2021). Leben mit Krebs, Leben nach Krebs („Cancer Survivorship"). In B. Alt-Epping, S. Fuxius, & U. Wedding (Eds.), Essentials Onkologie (2 ed.). München: Urban & Fischer in Elsevier. https://www.sciencedirect.com/science/article/abs/pii/B9783437214325000145
Arndt V, Dahm S, Kraywinkel K (2021). Krebsprävalenz in Deutschland 2017. Der Onkologe, 27(8), 717-723. https://doi.org/10.1007/s00761-021-00988-7
Arndt V, Mehnert-Theuerkauf A, Singer S, Höffken K. (2021) Cancer Survivorship – Leben mit Krebs/Leben nach Krebs. Der Onkologe, 27(8) 714-716. https://doi.org/10.1007/s00761-021-00992-x
Daskalakis M, Feller A, Noetzli J, Bonadies N, Arndt V, Baerlocher GM, The Nicer Working Group. (2021). Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017. Cancers (Basel), 13(24). https://doi.org/10.3390/cancers13246269
Doege D, Thong MSY, Weisser L, Koch-Gallenkamp L, Jansen L, Bertram H, . . . Arndt V. (2021). Health-Related Quality of Life in Very Long-Term Cancer Survivors 14-24 Years Post-Diagnosis Compared to Population Controls: A Population-Based Study. Cancers (Basel), 13(11). https://doi.org/10.3390/cancers13112754
Hermann S, Bergbold S, Mons U, Arndt V. (2021). Prävention am Beispiel von Krebserkrankungen. In B. Alt-Epping, S. Fuxius, & U. Wedding (Eds.), Essentials Onkologie (2 ed.). München: Urban & Fischer in Elsevier.
Jansen L, Kanbach J, Finke I, Arndt V, Emrich K, Holleczek B., . . . Group, F. (2021). Estimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany. Cancers (Basel), 13(2), 1-14. https://doi.org/10.3390/cancers13020357
Jansen L, Moratin J, Waldmann A, Zaoui K, Holleczek B, Nennecke A, . . . Arndt V. (2021). [Oral and pharyngeal cancer: incidence, mortality, and survival in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 64(8), 941-950. https://doi.org/10.1007/s00103-021-03368-z
Liu Z, Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, . . . Arndt V. (2021). Distress mediates the relationship between cognitive appraisal of medical care and benefit finding/posttraumatic growth in long-term cancer survivors. Cancer, 127(19), 3680-3690. https://doi.org/10.1002/cncr.33684
Liu Z, Thong MSY, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, . . . Arndt V. (2021). Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: results from a multi-regional population-based survey in Germany. Br J Cancer, 125(6), 877-883. https://doi.org/10.1038/s41416-021-01473-z
Scherer-Trame S, Jansen L, Arndt V, Chang-Claude J, Hoffmeister M, Brenner H. (2021). Inpatient rehabilitation therapy among colorectal cancer patients - utilization and association with prognosis: a cohort study. Acta Oncol, 60(8), 1000-1010. https://doi.org/10.1080/0284186X.2021.1940274
Thong MSY, Boakye D, Jansen L, Martens UM, Chang-Claude J, Hoffmeister M, . . . Arndt V. (2021). Comorbidities, Rather Than Older Age, Are Strongly Associated With Higher Utilization of Healthcare in Colorectal Cancer Survivors. J Natl Compr Canc Netw, 1-11. https://doi.org/10.6004/jnccn.2021.7030
Thong MSY, Chan RJ, van den Hurk C, Fessele K, Tan W, Poprawski D., . . . group M. E. w. (2021). Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship research. Support Care Cancer, 29(1), 7-10. https://doi.org/10.1007/s00520-020-05648-x
Weißer L, Finke I, Arndt V. (2021). Kardiovaskuläre Spätfolgen der Chemotherapie bei Darmkrebspatienten. Der Onkologe, 27(8), 724-738. https://doi.org/10.1007/s00761-021-00929-4
2020
Adam S, Diener EM, Camey B, Egger Hayouz C, Konzelmann I, Mousavi M, Herrmann C, Rohrmann S, Wanner M, Staehelin K, Strebel RT, Randazzo M, John H, Schmid HP, Arndt V. (2020). Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study. Cancer Med https://doi.org/10.1002/cam4.3197
Adam S, Doege D, Koch-Gallenkamp l, Thong MSY, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann M, Zeissig SR, Jansen L, Rohrmann S, Brenner H, Arndt V. (2020). Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study. Support Care Cancer 28(6): 2875-2885. https://doi.org/10.1007/s00520-019-05120-5
Arndt V. (2020). Cancer survivorship. best practice onkologie 15(3): 64-70.
Arndt V, Holleczek B, Kajuter B, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K; Katalinic A: (2020). Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives. Gesundheitswesen 82 (S 01): S62-S71. https://doi.org/10.1055/a-1009-6466
Doege D, Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, . . . Arndt V. (2020). Age-specific prevalence and determinants of depression in long-term breast cancer survivors compared to female population controls. Cancer Med, 9(22), 8713-8721. https://doi.org/10.1002/cam4.3476
Eyl RE, Koch-Gallenkamp L, Jansen L, Walter V, Carr PR, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V. (2020). Physical activity and long-term quality of life among colorectal cancer survivors - a population-based prospective study. Cancer Prev Res (Phila). https://doi.org/10.1158/1940-6207.CAPR-19-0377
Eyl RE, Thong MSY, Carr PR, Jansen L, Koch-Gallenkamp L, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V. (2020). Physical activity and long-term fatigue among colorectal cancer survivors – a population-based prospective study. BMC Cancer 20(1), 438 https://doi.org/10.1186/s12885-020-06918-x
Feller A, Matthes KL, Bordoni A, Bouchardy C, Bulliard JL, Herrmann C, Konzelmann I, Maspoli M, Mousavi M, Rohrmann S, Staehelin K, Arndt V, NICER Working Group (2020). The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study. BMC Cancer 20(1): 51. https://doi.org/10.1186/s12885-019-6452-0
Fröhling S, Arndt V, Task Force des Deutschen Krebsforschungszentrums (DKFZ), der Deutschen Krebshilfe, & der Deutschen Krebsgesellschaft. (2020). Corona-Effekt in der Onkologie - Versorgung von Krebspatienten. Dtsch Arztebl, 117(46), A2234-A2242
Jansen L, Hermann S, Bergbold S, Holleczek B, Heil J, Kraywinkel K, Arndt V. (2020). Überleben nach primär metastasiertem Brustkrebs. Der Onkologe 26 (6): 487-496. https://doi.org/10.1007/s00761-020-00772-z
Liu Z, Doege D, Thong MSY, Arndt V. (2020) The relationship between posttraumatic growth and health-related quality of life in adult cancer survivors: A systematic review. J Affect Disord. 276:159-168. https://doi.org/10.1016/j.jad.2020.07.044
Schmidt ME, Hermann S, Arndt V, Steindorf K. (2020). Prevalence and severity of long-term physical, emotional, and cognitive fatigue across 15 different cancer entities. Cancer Med. https://doi.org/10.1002/cam4.3413
Thong MSY, Jansen L, Chang-Claude J, Hoffmeister M, Brenner H, Arndt V. (2020). Association of laparoscopic colectomy versus open colectomy on the long-term health-related quality of life of colon cancer survivors. Surg Endosc. https://doi.org/10.1007/s00464-019-07360-2
Thong MSY, van Noorden CJF, Steindorf K, Arndt V. (2020). Cancer-Related Fatigue: Causes and Current Treatment Options. Curr Treat Options Oncol 21(2): 17. https://doi.org/10.1007/s11864-020-0707-5
Zeissig SR, Arndt V, Kraywinkel K. (2020). Beiträge der Epidemiologie bei der Sekundärprävention von Krebserkrankungen. Der Onkologe 26(5): 393-401
2019
Adam S, Diener EM, Schmid HP, Arndt V, PROCAS-study group. (2019). Prostate Cancer Survivorship in Switzerland (PROCAS): Study Protocol of the Swiss Multiregional Cohort. Swiss Cancer Bull, 39(3), 256-261.
Adam S, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Rohrmann S, Brenner H, Arndt V. (2019). Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study. Eur J Cancer Care (Engl), e13076. https://doi.org/doi:10.1111/ecc.13076
Adam S, van de Poll-Franse LV, Mols F, Ezendam NPM, de Hingh I, Arndt V, Thong MSY. (2019). The association of cancer-related fatigue with all-cause mortality of colorectal and endometrial cancer survivors: Results from the population-based PROFILES registry. Cancer Med, 8(6), 3227-3236. https://doi.org/doi:10.1002/cam4.2166
Arndt V. (2019). „Cancer survivorship“ in Deutschland – Epidemiologie und Definitionen. Forum, 34(2), 158-164. https://doi.org/doi:10.1007/s12312-019-0560-2
Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A. (2019) Data from population-based cancer registration for secondary data analysis: Methodological challenges and perspectives. [Daten bevölkerungsbezogener Krebsregister für die Sekundärdatenanalyse: Methodische Herausforderungen und Perspektiven]. Gesundheitswesen, (accepted 20.08.2019).
Arndt V, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Doege D, Thong MSY, Brenner H. (2019). Return to work after cancer. A multi-regional population-based study from Germany. Acta Oncol, 58(5), 811-818. https://doi.org/doi:10.1080/0284186X.2018.1557341
Arndt V, Kraywinkel K, Zeissig SR. (2019). Beiträge der Epidemiologie bei der Primärprävention von Krebserkrankungen. Der Onkologe, 25(S1), 7-13. https://doi.org/doi:10.1007/s00761-019-0600-7
Benzarti S, Daskalakis M, Feller A, Bacher VU, Schnegg-Kaufmann A, Rufer A, Holbro A, Schmidt A, Benz R, Solenthaler M, Stussi G, Arndt V, Bonadies N, Nicer Working Group. (2019). Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries. Cancer Epidemiol, 59, 51-57. https://doi.org/doi:10.1016/j.canep.2019.01.003
Doege D, Thong M, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. (2019). The role of psychosocial resources for long-term breast, colorectal, and prostate cancer survivors: prevalence and associations with health-related quality of life. Support Care Cancer, 27(1), 275-286. https://doi.org/doi:10.1007/s00520-018-4317-8
Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Jansen L, Brenner H, Arndt V. (2019). Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany. Breast Cancer Res Treat, 175(2), 499-510. https://doi.org/doi:10.1007/s10549-019-05188-x
Kollar A, Rothermundt C, Klenke F, Bode B, Baumhoer D, Arndt V, Feller A, Nicer Working Group. (2019). Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015. Cancer Epidemiol, 63, 101596. https://doi.org/doi:10.1016/j.canep.2019.101596
Thong MSY, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. (2019). Age at Diagnosis and Sex Are Associated With Long-term Deficits in Disease-Specific Health-Related Quality of Life of Survivors of Colon and Rectal Cancer: A Population-Based Study. Dis Colon Rectum, 62(11), 1294-1304. https://doi.org/doi:10.1097/DCR.0000000000001489
Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. (2019). Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - a population-based study(). Acta Oncol, 58(5), 801-810. https://doi.org/doi:10.1080/0284186X.2018.1557340
2018
Adam S, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig S, Brenner H, Rohrmann S, Arndt V. (2018). Health-Related Quality of Life in Long-Term Survivors with Localized Prostate Cancer by Type of Intervention. Oncology Research and Treatment, 41, 143-143. https://doi.org/doi:10.1111/ecc.13076
Andres M, Feller A, Arndt V, Nicer Working Group. (2018). Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013. Cancer Epidemiol, 53, 105-110. https://doi.org/doi:10.1016/j.canep.2018.01.015
Doege D, Thong M, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. (2018). The role of psychosocial resources for long-term breast, colorectal, and prostate cancer survivors: prevalence and associations with health-related quality of life. Paper presented at the Deutscher Krebskongress 2018, Berlin.
Eyl RE, Koch-Gallenkamp L, Jansen L, Walter V, Carr P, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V. (2018). Potential determinants of physical inactivity among long-term colorectal cancer survivors. J Cancer Surviv, 12(5), 679-690. https://doi.org/doi:10.1007/s11764-018-0705-9
Eyl RE, Xie K, Koch-Gallenkamp L, Brenner H, Arndt V. (2018). Quality of life and physical activity in long-term (>/=5 years post-diagnosis) colorectal cancer survivors - systematic review. Health Qual Life Outcomes, 16(1), 112. https://doi.org/doi:10.1186/s12955-018-0934-7
Lorez M, Galli F, Arndt V, Nicer Working Group. (2018) Swiss cancer prevalence and language region. Swiss Cancer Bulletin 38 (4350), 86-93
Lorez M, Nanieva R, Arndt V, Rohrmann S, Nicer Working Group. (2018). Benign and malignant primary brain tumours in the Swiss population (2010-2014). Swiss Cancer Bull, 38(2), 188-196.
Thong MSY, Mols F, Doege D, van de Poll-Franse, Arndt V. (2018). Population-based cancer survivorship research: Experiences from Germany and the Netherlands. Journal of Cancer Policy, 15, 87-91. https://doi.org/doi:10.1016/j.jcpo.2018.02.003
Thong MSY, Wolschon EM, Koch-Gallenkamp L, Waldmann A, Waldeyer-Sauerland M, Pritzkuleit R, Bertram H, Kajuter H, Eberle A, Holleczek B, Zeissig SR, Brenner H, Arndt V. (2018). "Still a Cancer Patient"-Associations of Cancer Identity With Patient-Reported Outcomes and Health Care Use Among Cancer Survivors. JNCI Cancer Spectr, 2(2), pky031. https://doi.org/doi:10.1093/jncics/pky031
2017
Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Hopfner S, Waldmann A, Zeissig SR, Brenner H (2017). Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol, 56(2), 190-197. https://doi.org/doi:10.1080/0284186X.2016.1266089
Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. (2017). Progredienzangst ≥5 Jahre nach Krebsdiagnose. [Fear of progression >= 5 years after diagnosis of cancer. Results of the cancer registry and population-based CAESAR study]. Der Onkologe, 23(4), 295-299. https://doi.org/doi:10.1007/s00761-017-0188-8
2016
Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Hopfner, S, Waldmann A, Zeissig SR, Brenner H, Arndt V. (2016). Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter? Health Psychol, 35(12), 1329-1333. https://doi.org/doi:10.1037/hea0000374